A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)
Terminated
Alza Corporation, DE, USA
2007-12-01
The purpose of the study is to document the use of fentanyl HCl 40 mcg system under routine
conditions and obtain a more comprehensive understanding of the safety of the system and
complications that may not be spontaneously reported.
An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients
Withdrawn
Alza Corporation, DE, USA
Phase 3
2008-10-01
The purpose of this study is to evaluate the safety and clinical utility of fentanyl HCl 40
mcg system for the management of postoperative pain in pediatric inpatients.
Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects
Completed
YM BioSciences
Phase 1
2001-10-01
This was a pilot, phase I, two-period, fasting, bioavailability, safety,and pharmacokinetic
study evaluating single dose of i.v. fentanyl (200 µg) and single doses of 2 mL or 3 mL
inhaled AeroLEF (500 µg/mL) delivered by nebulization with the AeroEclipse BAN device
administered in normal healthy non-smoking subjects.
Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic Surgery
Terminated
Janssen Cilag N.V./S.A.
Phase 4
2008-08-01
The purpose of this study is to evaluate in daily clinical practice the safety and efficacy
of fentanyl Iontophoretic Transdermal (through the skin) System (ITS) for management of
moderate (medium level of seriousness) to severe (very serious) acute (a quick and severe)
pain in participants who have undergone elective spine or orthopedic (related to bones)
surgery.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
